Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Int J Cardiol ; 220: 781-6, 2016 Oct 01.
Article in English | MEDLINE | ID: mdl-27394974

ABSTRACT

BACKGROUND: Device follow-up is mandatory in the care of patients with a pacemaker. However, in most cases, device checks appear to be mere technical, time-consuming procedures. The aim of this research is to evaluate whether remote follow-up can replace in-clinic device checks by assessing clinical outcomes for pacemaker patients followed only via remote follow-up. METHODS AND RESULTS: Consecutive pacemaker patients followed with remote monitoring were prospectively included by 6 Italian cardiology centers in an observational investigation. The workflow for remote monitoring included an initial assessment by nursing staff and, when necessary, by a responsible physician for medical decisions. No in-person visits were scheduled after the start of remote monitoring. One-thousand and two-hundred and fifty one patients (30% female, 75±11years old) were followed for a median observation period of 15months. Out of 4965 remote transmissions, 1882 (38%) had at least one clinically relevant event to be investigated further, but, only after 137 transmissions (2.8%), the patients were contacted for an in-clinic visit or hospitalization. Sixty-nine patients died and 124 were hospitalized for various reasons. Atrial fibrillation episodes were the most common clinical events discovered by remote transmissions, occurring in 1339 (26%) transmissions and 471 (38%) patients. CONCLUSIONS: Our experience shows that remote monitoring in a pacemaker population can safely replace in-clinic follow-up, avoiding unnecessary in-hospital device follow-up.


Subject(s)
Office Visits/trends , Pacemaker, Artificial/standards , Pacemaker, Artificial/trends , Remote Consultation/standards , Remote Consultation/trends , Aged , Aged, 80 and over , Atrial Fibrillation/diagnosis , Atrial Fibrillation/epidemiology , Atrial Fibrillation/prevention & control , Defibrillators, Implantable/standards , Defibrillators, Implantable/trends , Female , Follow-Up Studies , Humans , Italy/epidemiology , Male , Middle Aged , Prospective Studies , Remote Consultation/methods
2.
Ital Heart J ; 2(7): 513-8, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11501960

ABSTRACT

BACKGROUND: Calcium-lowering drugs seem to be able to reduce the recurrences of atrial fibrillation (AF) after cardioversion by preventing electrical remodeling of atrial cells. The aim of our study was to prospectively evaluate the efficacy of short-term verapamil therapy associated with propafenone or amiodarone in reducing recurrences of AF after low energy intracardiac cardioversion. METHODS: Eighty-two patients with chronic AF (mean duration 6.1 months, range 1-96 months) underwent low energy intracardiac cardioversion. Forty-one patients (Group A) were instructed to suspend antiarrhythmic therapy 48 hours before the procedure (only chronic amiodarone was allowed). The subsequent 41 patients (Group B), in addition to previous prescriptions, had to take verapamil (120 mg twice daily) for 3 days before low energy intracardiac cardioversion and for 7 days after cardioversion. A right atrium-coronary sinus or right atrium-left pulmonary artery electrode configuration was indifferently utilized. Propafenone (450-900 mg daily) or amiodarone (200 mg daily) was prescribed to all patients after cardioversion. RESULTS: Sinus rhythm was acutely restored in 80 patients (97.6%): the mean number of shocks delivered was 2.3 (range 1-5); the mean energy required was 10.5 J (range 7.2-19.8 J). No statistically significant differences were found between the right atrium-coronary sinus vs right atrium-left pulmonary artery electrode configuration regarding the energy required and the number of shocks delivered. Group A and Group B showed the same number of AF recurrences at the first month of follow-up. CONCLUSIONS: In our study, short-term verapamil treatment associated with propafenone or amiodarone seems to be useless for the prevention of recurrent AF after low energy intracardiac cardioversion.


Subject(s)
Anti-Arrhythmia Agents/therapeutic use , Atrial Fibrillation/prevention & control , Calcium Channel Blockers/therapeutic use , Verapamil/therapeutic use , Adult , Aged , Anti-Arrhythmia Agents/administration & dosage , Atrial Fibrillation/drug therapy , Atrial Function, Right/drug effects , Calcium Channel Blockers/administration & dosage , Electric Countershock , Female , Humans , Male , Middle Aged , Prospective Studies , Recurrence , Verapamil/administration & dosage
4.
Ital Heart J ; 1(2): 137-42, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10730614

ABSTRACT

BACKGROUND: Low energy intracardiac cardioversion has recently been introduced into clinical practice to treat both acute and chronic atrial fibrillation. It has also been suggested that low energy intracardiac cardioversion has a higher efficacy rate in restoring sinus rhythm than conventional external cardioversion. METHODS: A prospective study was started in 41 patients (mean age 64.5 years) with chronic atrial fibrillation (mean duration 6.5 months), in order to obtain more data on low energy intracardiac cardioversion concerning: 1) time required to perform low energy intracardiac cardioversion by single venous femoral approach; 2) acute efficacy; 3) incidence of complications; 4) persistence of sinus rhythm after 1 month. RESULTS: Twenty patients had right atrium-coronary sinus (Group A) and 20 right atrium-left pulmonary artery (Group B) electrode configuration for defibrillation. In 1 patient the configuration was not available. In all patients (100%) sinus rhythm was acutely restored. No statistically significant differences were found between the two groups concerning mean energy and impedance required to obtain cardioversion. With mild sedation the discomfort induced by the electrical shock was minimal or mild. Only 44% of patients were in sinus rhythm 1 month after low energy intracardiac cardioversion, in spite of adequate pharmacological therapy. CONCLUSIONS: Low energy intracardiac cardioversion by single venous femoral approach may be considered a very effective and not time consuming procedure in acutely restoring sinus rhythm, with low complication rate; in addition the procedure was well accepted by all patients.


Subject(s)
Atrial Fibrillation/therapy , Electric Countershock/methods , Adult , Aged , Chronic Disease , Electric Countershock/adverse effects , Female , Humans , Male , Middle Aged , Prospective Studies
5.
G Ital Cardiol ; 22(11): 1335-6, 1992 Nov.
Article in Italian | MEDLINE | ID: mdl-1297620

ABSTRACT

A twenty-nine-year-old woman, one week after a traumatic skin laceration on the territory of the distal part of the radial artery, developed a pulsating mass suggesting a pseudoaneurysm of the radial artery. Using the duplex color Doppler echography, we clearly demonstrated the anatomical damage, the presence of the false lumen and the continuity of the vessel. These observations were of great assistance for the subsequent surgical treatment.


Subject(s)
Aneurysm, False/diagnostic imaging , Echocardiography, Doppler , Radial Artery/diagnostic imaging , Radial Artery/injuries , Adult , Aneurysm, False/etiology , Female , Humans , Peripheral Vascular Diseases/diagnostic imaging , Peripheral Vascular Diseases/etiology , Rupture
7.
Minerva Cardioangiol ; 37(10): 451-6, 1989 Oct.
Article in Italian | MEDLINE | ID: mdl-2608177

ABSTRACT

From a group of 142 patient with atrial fibrillation or atrial flutter treated with DC shock, we selected 5 cases who showed a marked ST segment elevation immediately after electrical cardioversion. Only two patients, who received high voltage DC shock (950 and 1220 Joules) revealed prolonged and significant increase of CPK values. Our data suggest that ST segment transitory elevation after DC shock should probably not be considered a sign of myocardial injury even though this could be the case when high voltage DC shocks are used.


Subject(s)
Electric Countershock , Electrocardiography , Adult , Aged , Atrial Fibrillation/therapy , Atrial Flutter/therapy , Clinical Enzyme Tests , Creatine Kinase/blood , Female , Humans , Isoenzymes , Male , Middle Aged
8.
G Ital Cardiol ; 17(7): 601-4, 1987 Jul.
Article in Italian | MEDLINE | ID: mdl-3678711

ABSTRACT

The purpose of this study is to analyze the relationship between occurrence of hemorrhagic complications, kinetic of fibrinogen degradation-regeneration and the changes of prothrombin time (PT), partial thromboplastin time (PTT), after intravenous administration of Streptokinase (SK), 1.500.000 U., in acute myocardial infarction. 45 selected patients with acute myocardial infarction had pretreatment analysis and serial post-SK measurement of fibrinogen levels, PT, PTT (for 48 hours). Basal fibrinogen levels were 3.2 g/l and displayed significant depression for 18 hours (0.30-0.46 g/l) and normalization after 30 hours from SK infusion. Similar behaviour showed PT and PTT. Minor bleeding was identified in 25 patients. In bleeders mean fibrinogen levels, PT, PTT before and maximum changes after SK were not significantly different compared with non bleeders. We conclude that SK infusion produces important and prolonged changes of fibrinogen levels, PT, PTT; hemorrhagic risk is not related, however, to the extent of lytic state, but probably to pre-existent vascular derangement, predisposing to bleeding complications during fibrinolytic therapy. Therefore we believe to be prudent to delay the infusion of heparin for 12-18 hours after SK administration, when fibrinogen levels are beginning to increase.


Subject(s)
Hemorrhage/chemically induced , Myocardial Infarction/drug therapy , Streptokinase/adverse effects , Female , Fibrinogen/metabolism , Hemorrhage/blood , Humans , Male , Myocardial Infarction/blood , Myocardial Infarction/physiopathology , Prothrombin Time , Streptokinase/therapeutic use
9.
G Ital Cardiol ; 17(4): 289-94, 1987 Apr.
Article in Italian | MEDLINE | ID: mdl-3653584

ABSTRACT

The purpose of this study was to define the sequential changes in global and regional right ventricular function, using equilibrium gated radionuclide angiography, following transmural inferior myocardial infarction (IMI) and associated ischemic right ventricular involvement. 24 patients with IMI underwent radionuclide angiography within 72 hours of onset of chest pain; subsequent studies were done at 13 +/- 5 days and at 6 +/- 2 months. Scintigraphic evidence of ischemic right ventricular involvement was defined by depression of right ventricular ejection fraction (less than 40%) and regional wall motion abnormalities (hypo-a-dyskinesia of right ventricular free wall). Significant improvement of global right ventricular ejection fraction was observed in 15 patients at the second study, and in 21 patients at the third study. Right ventricular regional wall motion showed similar improvement from the initial to the final studies. Significant changes in right ventricular function occurred without concurrent changes in global and regional left ventricular ejection fraction. We concluded that patients with IMI and ischemic right ventricular involvement show frequently improvement of global and regional right ventricular function over time. This changes tend to occur early and without significant modifications in left ventricular function. The good prognosis observed in our patients, despite the high incidence of in hospital complications, might be related to the improvement of right ventricular function.


Subject(s)
Coronary Disease/physiopathology , Heart/physiopathology , Myocardial Infarction/physiopathology , Radionuclide Angiography/methods , Adult , Aged , Aged, 80 and over , Coronary Disease/diagnostic imaging , Female , Follow-Up Studies , Heart/diagnostic imaging , Heart Ventricles/diagnostic imaging , Heart Ventricles/physiopathology , Humans , Male , Middle Aged , Myocardial Infarction/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...